BioCentury
ARTICLE | Financial News

Avigen raises $62.2 million

November 2, 2000 8:00 AM UTC

Gene therapy company AVGN raised $62.2 million in a public offering of 1.7 million shares at $37.50. The shares were sold from a shelf registration filed in October covering the resale of up to $120 m...